Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence

Oncological Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence After Mastectomy

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06088719

Enrollment

300

Registered

2023-10-18

Start date

1989-01-01

Completion date

2024-12-31

Last updated

2023-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Recurrent Disease

Brief summary

The axillary management of breast cancer patients with operable isolated chest wall recurrence after mastectomy is unclear. We aim to determine if axillary restaging surgery can be safely omitted with no increased recurrences in this group of patients.

Interventions

PROCEDUREaxillary surgery

one group undergoes axillary surgery

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

Mastectomy patients who developed pathologically confirmed invasive isolated chest wall recurrence. \-

Exclusion criteria

-Patients with bilateral cancers * Patients with evidence of concomitant distant or/and regional recurrences * Patients who did not have surgery for their isolated chest wall recurrences.

Design outcomes

Primary

Measure	Time frame	Description
recurrence	from date of surgery to date of recurrence, up to 5 years	axillary or distant recuurences

Countries

Singapore

Contacts

Primary ContactGeok hoon lim

lim.gh@singhealth.com.sg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026